Latest Breaking News On - Supernus pharmaceuticals - Page 3 : comparemela.com

Catalyst Watch: AI in the spotlight with Nvidia earnings, Microsoft Build, and IBM event

Catalyst Watch: AI in the spotlight with Nvidia earnings, Microsoft Build, and IBM event
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Hong kongUnited statesAviation administrationAviation administration michael whitakerDominion bankSupernus pharmaceuticalsUniversity of michiganSeeking alphaCatalyst watchToronto dominion bankRalph laurenPolestar automotiveFederal aviationJames financialInvestment conferenceBooz allen hamilton

Newron Reports Compelling Additional Data Documenting the Efficacy of Evenamide in Pivotal Study 008A in Poorly Responding Schizophrenia Patients

Newron Reports Compelling Additional Data Documenting the Efficacy of Evenamide in Pivotal Study 008A in Poorly Responding Schizophrenia Patients
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Kyongsang buktoSouth koreaUnited arab emiratesUnited statesUnited kingdomRavi anandSwiss exchangeDusseldorf stock exchangeSupernus pharmaceuticalsNewron pharmaceuticalsEuropean unionNegative syndrome scaleTotal scoreClinical global impressionChief medical officerLatin america

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus
bdtonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bdtonline.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkCity ofUnited kingdomFrance generalTel avivAbrahaml pomerantzDanielle peytonLos angelesCompany new drug applicationSupernus pharmaceuticals incSupernus pharmaceuticalsComplete response letterNew drug application

SUPN Stock Earnings: Supernus Pharmaceuticals Misses Revenue for Q1 2024

SUPN Stock Earnings: Supernus Pharmaceuticals Misses Revenue for Q1 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Supernus pharmaceuticalsPlace earnings

Supernus Pharmaceuticals, Inc (NASDAQ:SUPN) Q1 2024 Earnings Call Transcript

Supernus Pharmaceuticals, Inc (NASDAQ:SUPN) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Tim decPeter vozzoJack khattarSupernus pharmaceuticals incSupernus pharmaceuticals first quarterBiggest oil producing countries in asiaSupernus pharmaceuticalsCall transcript mayResults conferenceInvestor relationsSupernus pharmaceuticalSupernu chief executive officerChief financial officerRisk factorsCelebrities actually wearOil producing countries